Impact of the COVID-19 Pandemic on Infective Endocarditis Management and Outcomes: Analysis of a National Clinical

Alexandra Novelli1, Arnar B Ingason2, Caroline Jirka2

  • 1Department of Medicine, Duke University School of Medicine, Durham, North Carolina.

PubMed

Insights

The COVID-19 pandemic worsened outcomes for general infective endocarditis (IE) admissions but improved mortality for valve surgery patients. This study analyzed national IE trends before and after the pandemic declaration, revealing significant shifts in patient complexity and survival rates.

Area of Science:

  • Cardiology and Infectious Diseases
  • Healthcare Management and Outcomes Research
  • Epidemiology of Cardiovascular Infections

Background:

  • The COVID-19 pandemic significantly disrupted healthcare delivery globally.
  • The specific impact of the pandemic on infective endocarditis (IE) management and outcomes, particularly valve surgery, remained unclear.
  • Understanding these shifts is crucial for optimizing patient care during public health crises.

Purpose of the Study:

  • To compare national trends in infective endocarditis (IE) admissions, patient demographics, and clinical outcomes before and after the onset of the COVID-19 pandemic.
  • To evaluate the impact of the pandemic on patients undergoing valve surgery for IE.
  • To identify changes in IE patient complexity and associated mortality rates.

Main Methods:

  • Utilized a national sample of IE admissions from the Vizient Clinical Database (2016-2022).
  • Defined pre-COVID-19 and post-COVID-19 periods based on the pandemic declaration in Q2 2020.
  • Employed 2-sample t tests, chi-square tests, and propensity score-matched analyses to compare baseline characteristics and outcomes between the two periods for all IE admissions and those involving valve surgery.

Main Results:

  • Post-pandemic IE admissions showed increased in-hospital mortality (11.4% vs 12.4%), stroke (4.9% vs 6.0%), myocardial infarction (1.3% vs 1.4%), and aspiration pneumonia (1.8% vs 2.4%) in the matched analysis.
  • Patients undergoing valve surgery during the pandemic experienced decreased in-hospital mortality (7.7% vs 6.7%) and shorter intensive care unit stays (8.5 vs 8.0 days) in the matched analysis.
  • Overall IE admissions decreased significantly post-pandemic (82,867 to 45,672) as did valve surgery admissions (11,337 to 6,322).

Conclusions:

  • Patients admitted with infective endocarditis after the COVID-19 onset were more medically complex, exhibiting worsened outcomes and higher mortality.
  • Conversely, patients undergoing valve surgery for IE demonstrated improved mortality and stable outcomes despite the pandemic's challenges.
  • These findings highlight a divergence in pandemic impact based on IE management strategy, emphasizing the resilience of surgical interventions.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
8
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
12
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
15
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
11
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
7
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13